Merck begins trial evaluating Zilovertamab Vedotin for previously untreated Diffuse Large B-Cell Lymphoma Ruchika Sharma9 Feb 2025 10:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial...
USFDA accepts application for Roche Columvi combination for relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma5 Dec 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...
CDSCO Panel approves Roche Products' Polatuzumab Vedotin for Injection 30mg per vial for Diffuse large B-cell lymphoma Dr. Divya Colin30 Nov 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Roche's proposal...
Recalculate sample size based on serious adverse event: CDSCO Panel Tells Roche on Polatuzumab vedotin study Dr. Divya Colin25 March 2024 6:00 PM ISTNew Delhi: In line with the Phase IV clinical trial protocol of Polatuzumab Vedotin for Injection, 30mg/vial and 140 mg/vial, the Subject Expert...
AbbVie gets USFDA nod for EPKINLY to treat adult patients with relapsed or refractory Diffuse Large B-Cell Lymphoma Ruchika Sharma20 May 2023 11:30 AM ISTDLBCL is a type of aggressive, fast-growing non-Hodgkin's lymphoma, a cancer that develops in the lymphatic system and affects B cells, a type of...
USFDA nod to Roche's Polivy in combination with R-CHP for certain types of previously untreated diffuse large B-cell lymphoma Ruchika Sharma20 April 2023 2:30 PM ISTPolivy is a first-in-class anti-CD79b antibody-drug conjugate.
Pfizer, MorphoSys and Incyte enter trial collaboration for Monjuvi in combination with TTI-622 Ruchika Sharma15 Jun 2022 10:00 AM ISTUnder the terms of the agreement, Pfizer will initiate a multicenter, international Phase 1b/2 study of TTI-622 with Monjuvi and lenalidomide for...
Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma Hina Zahid12 Jan 2022 9:00 AM ISTNew evidence suggests that adding the targeted therapy ibrutinib (Imbruvica) to a standard chemotherapy regimen can improve how long some younger...
Omega-3 fatty acids intake during pregnancy may protect offsprings from breast cancer Hina Zahid30 Jun 2021 9:00 AM ISTHUNTINGTON, W.Va. - Studies in the past have revealed that Diets rich in omega-3 fatty acids (FA) have been associated with lowered risks of...
FDA approves new gene therapy for non-Hodgkin lymphomas Dr. Kamal Kant Kohli6 Feb 2021 4:02 AM ISTThe U.S. Food and Drug Administration has approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain...
